Sixiu Chen

443 total citations
22 papers, 323 citations indexed

About

Sixiu Chen is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Sixiu Chen has authored 22 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Nephrology and 5 papers in Genetics. Recurrent topics in Sixiu Chen's work include Genetic and Kidney Cyst Diseases (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Dialysis and Renal Disease Management (3 papers). Sixiu Chen is often cited by papers focused on Genetic and Kidney Cyst Diseases (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Dialysis and Renal Disease Management (3 papers). Sixiu Chen collaborates with scholars based in China, United States and Switzerland. Sixiu Chen's co-authors include Hongmei Zhou, Wenxia Meng, Xin He, Qinghong Gao, Lanyan Wu, Lin Zhang, Qingjie Xia, Changlin Mei, Bo Yang and Xiangli Kong and has published in prestigious journals such as Cancer Research, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Sixiu Chen

22 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sixiu Chen China 11 161 68 53 38 36 22 323
Liang Deng China 15 327 2.0× 74 1.1× 74 1.4× 65 1.7× 62 1.7× 42 521
Shamini G. Shekeran Singapore 10 174 1.1× 76 1.1× 37 0.7× 28 0.7× 78 2.2× 11 427
Kozue Uchio Japan 10 145 0.9× 27 0.4× 27 0.5× 30 0.8× 28 0.8× 12 346
Yan Qi China 11 173 1.1× 62 0.9× 33 0.6× 14 0.4× 83 2.3× 26 361
Wanjun Shen China 10 118 0.7× 60 0.9× 33 0.6× 16 0.4× 89 2.5× 28 314
Maylin Almonte‐Becerril Mexico 8 174 1.1× 43 0.6× 77 1.5× 23 0.6× 41 1.1× 20 440
Subhashree Pradhan United States 10 178 1.1× 44 0.6× 45 0.8× 30 0.8× 36 1.0× 17 346
Madalina-Viviana Nastase Germany 7 219 1.4× 28 0.4× 85 1.6× 24 0.6× 128 3.6× 7 461

Countries citing papers authored by Sixiu Chen

Since Specialization
Citations

This map shows the geographic impact of Sixiu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sixiu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sixiu Chen more than expected).

Fields of papers citing papers by Sixiu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sixiu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sixiu Chen. The network helps show where Sixiu Chen may publish in the future.

Co-authorship network of co-authors of Sixiu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Sixiu Chen. A scholar is included among the top collaborators of Sixiu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sixiu Chen. Sixiu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xinrong, et al.. (2024). New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era. Frontiers in Immunology. 15. 1342837–1342837. 15 indexed citations
2.
Zhang, Meng, Yiqin Wang, Peng Xie, et al.. (2024). Association of systemic immune-inflammation index with all-cause and cardio-cerebrovascular mortality in individuals with diabetic kidney disease: evidence from NHANES 1999-2018. Frontiers in Endocrinology. 15. 1399832–1399832. 2 indexed citations
3.
Chen, Sixiu, Fan Li, Nan Chen, et al.. (2024). Effects of Ketoanalogue Supplements on Patients Receiving Continuous Ambulatory Peritoneal Dialysis: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study. Journal of Renal Nutrition. 35(3). 463–471. 1 indexed citations
4.
Chen, Sixiu, et al.. (2024). Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in Patients with Lupus Nephritis. Medicina. 60(6). 988–988. 2 indexed citations
5.
Jia, Xiuzhi, Li Tan, Sixiu Chen, Ruihan Tang, & Wei Chen. (2023). Monogenic lupus: Tracing the therapeutic implications from single gene mutations. Clinical Immunology. 254. 109699–109699. 7 indexed citations
6.
Xue, Cheng, Sixiu Chen, Bo Yang, et al.. (2021). Comparison of Outcomes between Percutaneous and Surgical Placement of Peritoneal Dialysis Catheters in Uremic Patients: A Meta-Analysis. Blood Purification. 51(4). 328–344. 3 indexed citations
7.
Xu, Jing, et al.. (2021). The Role of Renal Pathology in the Prognosis and Recovery of Community-Acquired Acute Kidney Injury. ˜The œNephron journals/Nephron journals. 145(4). 353–362. 2 indexed citations
8.
Chen, Sixiu, Qingzhou Zhang, Lili Fu, et al.. (2021). NS398 as a potential drug for autosomal‐dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models. Journal of Cellular and Molecular Medicine. 25(20). 9597–9608. 3 indexed citations
9.
Yang, Bo, Sixiu Chen, Ming Wu, et al.. (2020). Author Correction: PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury. Scientific Reports. 10(1). 6036–6036. 1 indexed citations
10.
Liu, Dongmei, Sixiu Chen, Bo Yang, et al.. (2019). Identification of Key Genes and Candidated Pathways in Human Autosomal Dominant Polycystic Kidney Disease by Bioinformatics Analysis. Kidney & Blood Pressure Research. 44(4). 533–552. 13 indexed citations
11.
Chen, Xujiao, Shouhong Gao, Sixiu Chen, et al.. (2018). Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis. Bioscience Reports. 38(5). 10 indexed citations
12.
Yang, Bo, Sixiu Chen, Ming Wu, et al.. (2017). PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury. Scientific Reports. 7(1). 39888–39888. 9 indexed citations
13.
Wu, Ming, Shuqin Mei, Ying Jing, et al.. (2016). Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation. Nephrology Dialysis Transplantation. 31(11). 1826–1834. 50 indexed citations
14.
Yang, Bo, Sixiu Chen, Guang Yang, et al.. (2015). New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol. BMJ Open. 5(11). e008440–e008440. 3 indexed citations
15.
Meng, Wenxia, Xin He, Chuanxia Liu, et al.. (2014). A Systems Biology Approach Identifies Effective Tumor–Stroma Common Targets for Oral Squamous Cell Carcinoma. Cancer Research. 74(8). 2306–2315. 33 indexed citations
16.
Kong, Xiangli, Xiaoqin Yang, Jinglin Zhou, et al.. (2014). Analysis of plasma metabolic biomarkers in the development of 4-nitroquinoline-1-oxide-induced oral carcinogenesis in rats. Oncology Letters. 9(1). 283–289. 26 indexed citations
17.
Feng, Yun, Jiao Chen, Yan Li, et al.. (2013). Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1 surface expression. Oncology Letters. 5(5). 1519–1526. 13 indexed citations
18.
Meng, Wenxia, Qingjie Xia, Lanyan Wu, et al.. (2011). Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts. BMC Cancer. 11(1). 88–88. 65 indexed citations
19.
Jing, Wei, Jingang Xiao, Xingmei Yang, et al.. (2010). Explant Culture: An Efficient Method to Isolate Adipose‐Derived Stromal Cells for Tissue Engineering. Artificial Organs. 35(2). 105–112. 30 indexed citations
20.
Liu, Jun, Zhihe Zhao, Ling Zou, et al.. (2009). Pressure-Loaded MSCs During Early Osteodifferentiation Promote Osteoclastogenesis by Increase of RANKL/OPG Ratio. Annals of Biomedical Engineering. 37(4). 794–802. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026